SAS Output

20-AUG-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 987 20 1044 71 864 142 864
ERLYTX 444 4 209 11 134 21 128
GI 175 0 0 2 24 9 55
GU 316 5 261 34 414 67 408
LEUK 85 2 104 12 146 30 183
LUNG 284 2 104 19 231 40 244
LYMPH 18 0 0 1 12 2 12
MELAN 152 4 209 6 73 13 79
MMYEL 84 0 0 4 49 7 43
OTHER 51 1 52 7 85 11 67
SXQOL 6 0 0 0 0 2 12
Total 2602 38 1983 167 2032 344 2095

20-AUG-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  6 3 157 5 61 6 37
BREAST 223 3 157 23 280 59 359
CCD 1506 19 991 86 1047 197 1199
LEUK 11 0 0 0 0 4 24
LUNG 635 13 678 63 767 118 718
PREV 84 0 0 1 12 9 55
SURV 96 1 52 8 97 16 97
SXQOL 3 0 0 0 0 0 0
Total 2564 39 2035 186 2264 409 2489

20-AUG-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  6 3 157 5 61 6 37
BREAST 1210 23 1200 94 1144 201 1224
CCD 1506 19 991 86 1047 197 1199
ERLYTX 444 4 209 11 134 21 128
GI 175 0 0 2 24 9 55
GU 316 5 261 34 414 67 408
LEUK 96 2 104 12 146 34 207
LUNG 919 15 783 82 998 158 962
LYMPH 18 0 0 1 12 2 12
MELAN 152 4 209 6 73 13 79
MMYEL 84 0 0 4 49 7 43
OTHER 51 1 52 7 85 11 67
PREV 84 0 0 1 12 9 55
SURV 96 1 52 8 97 16 97
SXQOL 9 0 0 0 0 2 12
Total 5166 77 4018 353 4296 753 4585

20-AUG-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 587 11 574 47 572 98 597
ERLYTX 286 4 209 10 122 15 91
GI 112 0 0 2 24 7 43
GU 209 2 104 18 219 38 231
LEUK 55 1 52 5 61 18 110
LUNG 207 2 104 15 183 33 201
LYMPH 17 0 0 1 12 2 12
MELAN 95 3 157 5 61 10 61
MMYEL 83 0 0 3 37 6 37
OTHER 51 1 52 7 85 11 67
SXQOL 6 0 0 0 0 2 12
Total 1708 24 1252 113 1376 240 1462

20-AUG-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  6 3 157 5 61 6 37
BREAST 222 2 104 22 268 58 353
CCD 1076 13 678 60 731 153 931
LEUK 11 0 0 0 0 4 24
LUNG 443 8 417 47 572 87 530
PREV 64 0 0 1 12 6 37
SURV 66 1 52 5 61 12 73
SXQOL 3 0 0 0 0 0 0
Total 1891 27 1408 140 1705 326 1985

20-AUG-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  6 3 157 5 61 6 37
BREAST 840 14 730 73 889 162 986
CCD 1076 13 678 60 731 153 931
ERLYTX 286 4 209 10 122 15 91
GI 155 1 52 12 146 25 152
GU 209 2 104 18 219 38 231
LEUK 75 4 209 10 122 27 164
LUNG 650 10 522 62 755 120 731
LYMPH 12 0 0 0 0 1 6
MELAN 75 3 157 5 61 10 61
MMYEL 83 0 0 3 37 6 37
OTHER 60 1 52 6 73 10 61
PREV 64 0 0 1 12 6 37
SURV 66 1 52 5 61 11 67
SXQOL 9 0 0 0 0 2 12
Total 3666 56 2922 270 3289 592 3604

20-AUG-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 758 10 522 41 499 83 505
ERLYTX 406 1 52 3 37 8 49
GI 123 0 0 0 0 2 12
GU 256 5 261 30 365 51 310
LEUK 59 2 104 11 134 25 152
LUNG 210 0 0 13 158 22 134
LYMPH 6 0 0 0 0 0 0
MELAN 141 3 157 5 61 12 73
MMYEL 4 0 0 1 12 2 12
Total 1963 21 1096 104 1266 205 1247

20-AUG-2018 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1408 27 1409 112 1364 226 1376
AFFIL 204 4 209 20 244 53 323
CCOP/NCORP 1987 20 1044 121 1473 287 1747
Non-SWOG 1562 21 1096 95 1157 182 1108
Total 5161 72 3758 348 4238 748 4554

20-AUG-2018 6:10

STUDIES OPENED THIS MONTH

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK S1712 CML, chronic phase, TKI +/- Ruxolitinib 1 Y 20-JUL-18
LUNG S1701 Thymic Adv, Carbo/Pac/Ram vs. Carbo/Pac 1 Y 09-AUG-18

20-AUG-2018 6:10

STUDIES CLOSED THIS MONTH

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LUNG S1400G HRRD: Talazoparib (BMN 673) 1 N 23-JUL-18

20-AUG-2018 6:10

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Registrations
CCD S1415CD TrACER CSF Standing Order Intervention for FN 1 17
LUNG A151216 ALCHEMIST0 - screening 0 8
LUNG A151216 ALCHEMIST0 - screening 1 7
BREAST S1207 Brst,Adj,Endocrine+/-Everolimus 1 6
LUNG S1400 SCCA,Adv, Biomarker Master 1 6
LEUK S1612 AML/MDS, Age 60+, Aza/Novel Therapeutics 1 5
BREAST A011106 Breast, Neoadj, ALTERNATE study 1 4
BREAST A011401 Breast, adj, Stage II/III HER2-, weight loss 2 4
BREAST A011401 Breast, adj, Stage II/III HER2-, weight loss 1 4
BREAST S1418 Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 2 4
BREAST S1418 Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 4
BREAST A011202 Breast, Nodal XRT +/- ALND 0 3
ERLYTX A071102 GBM, adj TMZ +/- Veliparib 1 3
LUNG S1400 SCCA,Adv, Biomarker Master 2 3
GU S1605 Blad, BCG-Unresponsive NMIBC, Atezolizumab 1 3
MELAN S1616 MELAN, Adv, Ipilimumab Nivolumab 1 3